>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
: CRAY -21.2%, GLUU -15.7%, CALD -13.4%, BGFV -9.9%, OMF -9.7%, KFRC -8.8%, SYRG -7.8%, (Synergy Resources confirms acquisition of certain assets from Noble Energy (NBL) for $505 mln in cash, and announces two separate divestitures in Adams County for ~$27 mln in cash; announces 45 mln share underwritten public offering ), MYGN -7.4%, CHEF -6.8%, RUBI -6.8%, RUBI -6.8%, CLH -5.9%, TXMD-5.1%, ILMN -5%, WD -4.8%, ENPH -4.5%, CERS -4.2%, SERV -4.1%, MDCA -4%, ATRO -3.8%, HCI -3.2%, PZZA -2.9%, VRSK -2.8%, BUD -2.4%, KATE-2.3%, RDS.B -2.2%, SHLX -2.1%, MB -2%, HUM -2%, GMED -1.9%, AMED -1.8%, SUM -1.6%, USNA -1.3%, NYMT -1.2%, VOYA -1.2%, SE -1.2%

Select EU Pharma names showing weakness: SHPG -2.6%, GSK -2.3%, AZN -2.1%, NVS -1.1%, NVO -0.6%

Select metals/mining stocks trading lower: BBL -5.7%, AU -2.1%, RIO -1.4%, CLF -1.1%, X -1.1%, MT -1.1%, PAAS -1.1%, ABX -1%, GDX -0.9%, NEM -0.8%

Other news: SYRG -10% (Noble Energy sells certain oil and natural gas properties, including the ~33,100 primarily undeveloped net acres within the DJ Basin, in the Greeley Crescent area for $505 mln to Synergy Resources), RLYP -9.6% (secures $150 mln in aggregate principal amount of senior secured term loans April 2022), BHP -5.5% (The Federal Public Prosecution Service has announced that it has commenced proceedings against Samarco Mineração, Vale (VALE) and BHP Billiton Brasil LTDA (BHP) for BRL 155 bln), UA -3.9% (Under Armour announces retirement of Chief Merchandising Officer Henry Stafford, effective July 2016), ACAD -3.2% ( details post-marketing studies following NUPLAZID FDA approval), STKL -3% (SunOpta voluntarily recalls a limited number of sunflower kernel products that have the potential to be contaminated with Listeria Monocytogenes), VALE -2.3% (The Federal Public Prosecution Service has announced that it has commenced proceedings against Samarco Mineração, Vale (VALE) and BHP Billiton Brasil LTDA (BHP) for BRL 155 bln), CTRP -2.3% (in smypathy with PCLN (reported earnings)), EXPE -2.1% (in smypathy with PCLN (reported earnings)),STRL -1.9% (prices 4,500,000 shares of its common stock at $4.00 per share)

Analyst comments: RAIL -2.2% (downgraded to Neutral from Buy at Longbow), MOH -1.7% (downgraded to Sell from Neutral at Goldman), BZH -1.4% (downgraded to Neutral from Buy at UBS), KBH -1.4% (downgraded to Sell from Neutral at UBS), UBS -0.8% (downgraded to Equal Weight from Overweight at Morgan Stanley)